👀 Ones to watch: The MOST undervalued stocks to buy right nowSee Undervalued Stocks

Boralex stock target cut, maintains Outperform on weaker results

EditorNatashya Angelica
Published 15/11/2024, 16:06
BLX
-

On Friday, BMO Capital Markets adjusted its outlook on Boralex (BLX:CN) (OTC: BRLXF) shares, reducing the price target to Cdn$45.00 from the previous Cdn$46.00, while continuing to endorse the stock with an Outperform rating. The adjustment follows the company's third-quarter results for 2024, which did not meet expectations due to weaker-than-anticipated wind resources.

The analyst from BMO Capital pointed out that despite the lower-than-expected performance in the third quarter, Boralex's growth backlog is progressing effectively. A significant highlight is the advancement of $769 million worth of battery storage projects in Ontario to the construction phase. This development is expected to contribute substantially to Boralex's growth in 2025 and even more significantly in 2026.

Boralex has been recognized for maintaining a strong balance sheet and a high-quality asset base. Approximately 91% of its assets are contracted, with an average contract length of 11 years. This stability is a cornerstone of the company's financial health and is anticipated to support its growth trajectory.

The BMO Capital analyst also noted the attractive valuation of Boralex's stock. With an estimated 9.5 times 2026 EBITDA, Boralex is valued lower than the average of approximately 12 times EBITDA for its renewable power peers. This valuation, alongside the company's solid fundamentals, underpins the decision to maintain the Outperform rating despite the slight reduction in the price target.

In summary, BMO Capital Markets views Boralex as a strong player in the renewable energy sector, poised for significant growth in the coming years, backed by its advancing project portfolio and solid financial positioning. The new price target reflects a marginal adjustment based on recent performance, but the overall outlook for the company remains positive.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2024 - Fusion Media Limited. All Rights Reserved.